Interpace

IDXG NASDAQ
0.8364
-0.0136
-1.60%
After Hours: 0.8060 -0.0304 -3.63% 16:30 07/19 EDT
Open
0.8288
Prev Close
0.8500
High
0.8500
Low
0.8000
Volume
152.88K
Avg Vol (3M)
268.08K
52 Week High
1.780
52 Week Low
0.6727
% Turnover
0.40%
Market Cap
31.86M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Interpace IDXG stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Interpace Diagnostics Group, Inc., formerly PDI, Inc., is focused on developing and commercializing molecular diagnostic tests principally focused on early detection of high potential progressors to cancer and leveraging the latest technology and personalized medicine for patient diagnosis and management. The Company operates through molecular diagnostics segment. It offers molecular tests, such as PancraGen, which is a pancreatic cyst molecular test that can aid in pancreatic cyst diagnosis and pancreatic cancer risk assessment utilizing its PathFinder platform; ThyGenX, which assesses thyroid nodules for risk of malignancy, and ThyraMIR, which assesses thyroid nodules risk of malignancy utilizing a gene expression assay. Through its molecular diagnostics business, the Company provides diagnostic options for detecting genetic and other molecular alterations that are associated with gastrointestinal and endocrine cancers, which are focused on early detection of cancer.
MORE >

Recently

Name
Price
%Change